Acta oto-laryngologica · 2026
Identification and characterization of a novel p. S390C variant in TMC1 in an autosomal recessive family with non-syndromic hearing loss.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dong Hui, Wu Yuxuan, Li Lei
Аннотация
BACKGROUND: TMC1 variants cause autosomal dominant (DFNA36) and recessive (DFNB7/11) sensorineural hearing loss. However, the clinical significance of novel missense variants, particularly in East Asian populations, remains unclear.
OBJECTIVE: Our study aims to clarify the pathogenicity of a novel variant p.S390C by clinical characterization, genetic and molecular model analysis in China.
MATERIAL AND METHODS: Auditory features of the hearing loss were characterized in proband. Variant screening of 406 known deafness-associated genes was performed in proband by targeted next-generation sequencing, confirmed by Sanger sequencing. Variant analysis was prediction computational and molecular model analysis.
RESULTS: Consistent with typical DFNB7 phenotype, the proband in this study showed congenital profound hearing loss. Targeted next-generation sequencing identified a compound heterozygous mutation: p. S390C variant and p.R34X variant in TMC1. Prediction computational analysis of protein functional damage and 3D modeling analysis consistently support that the p. S390C in TMC1 is pathogenic.
CONCLUSIONS AND SIGNIFICANCE: The p. S390C variant in TMC1 gene is highly likely to be pathogenic and associated with autosomal recessive hearing loss. Our study expanded the mutation spectrum of the TMC1 gene, providing deeper insights into the genotype-phenotype correlations of hereditary deafness, which holds significant implications for genetic diagnosis and counseling in affected families.
OBJECTIVE: Our study aims to clarify the pathogenicity of a novel variant p.S390C by clinical characterization, genetic and molecular model analysis in China.
MATERIAL AND METHODS: Auditory features of the hearing loss were characterized in proband. Variant screening of 406 known deafness-associated genes was performed in proband by targeted next-generation sequencing, confirmed by Sanger sequencing. Variant analysis was prediction computational and molecular model analysis.
RESULTS: Consistent with typical DFNB7 phenotype, the proband in this study showed congenital profound hearing loss. Targeted next-generation sequencing identified a compound heterozygous mutation: p. S390C variant and p.R34X variant in TMC1. Prediction computational analysis of protein functional damage and 3D modeling analysis consistently support that the p. S390C in TMC1 is pathogenic.
CONCLUSIONS AND SIGNIFICANCE: The p. S390C variant in TMC1 gene is highly likely to be pathogenic and associated with autosomal recessive hearing loss. Our study expanded the mutation spectrum of the TMC1 gene, providing deeper insights into the genotype-phenotype correlations of hereditary deafness, which holds significant implications for genetic diagnosis and counseling in affected families.